NANOVIBRONIX INC (NAOV) Stock Overview
USA - NASDAQ:NAOV - US63008J8844 - Common Stock
NAOV Key Statistics, Chart & Performance
The current stock price of NAOV is 5.8 USD. In the past month the price decreased by -9.09%. In the past year, price decreased by -99.03%.
NAOV Latest News, Press Relases and Analysis
NAOV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
Related stock screener links
About NAOV
Company Profile
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The firm's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Company Info
NANOVIBRONIX INC
969 Pruitt Piace
Tyler TEXAS 10523 US
CEO: Brian Murphy
Employees: 31
Phone: 19142333004
NANOVIBRONIX INC / NAOV FAQ
What does NANOVIBRONIX INC do?
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The firm's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
What is the stock price of NANOVIBRONIX INC today?
The current stock price of NAOV is 5.8 USD. The price decreased by -1.53% in the last trading session.
What is the dividend status of NANOVIBRONIX INC?
NAOV does not pay a dividend.
What is the ChartMill technical and fundamental rating of NAOV stock?
NAOV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is NAOV stock listed?
NAOV stock is listed on the Nasdaq exchange.
What is NANOVIBRONIX INC worth?
NANOVIBRONIX INC (NAOV) has a market capitalization of 5.05M USD. This makes NAOV a Nano Cap stock.
What is the next earnings date for NAOV stock?
NANOVIBRONIX INC (NAOV) will report earnings on 2025-11-12.
NAOV Technical Analysis
NAOV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NAOV. Both the profitability and financial health of NAOV have multiple concerns.
NAOV Financial Highlights
Over the last trailing twelve months NAOV reported a non-GAAP Earnings per Share(EPS) of -122.19. The EPS increased by 15.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| Debt/Equity | 0.05 |